ProCE Banner Activity

Maintenance Lapatinib After Chemotherapy in HER1/2-Positive Metastatic Bladder Cancer

Slideset Download
Conference Coverage
Results of the first randomized, individualized therapy study in metastatic bladder cancer.

Released: June 04, 2015

Expiration: June 02, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation